Effects of hypoxia-inducible factor-1α silencing on the proliferation of cbrh-7919 hepatoma cells

World Journal of Gastroenterology

Volumn 19, Issue 11, 2013, Pages 1749-1759

  Wu, Yu Dan ^a   Xu, Lin Feng ^a   Ni, Jia Yan ^a   Sun, Hong Liang ^a   Chen, Yao Ting ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

CBRH 7919 hepatoma cells; Hypoxia inducible factor 1 ; Protein kinase B; RNA interference; Vascular endothelial growth factor

Indexed keywords

CYCLIN D1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; PROTEIN KINASE B; PROTEIN P21; SMALL INTERFERING RNA; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; GENE SILENCING; HYPOXIA; LIVER CELL CARCINOMA; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84875395847     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i11.1749     Document Type: Article

References (41)

1. Ferenci P, Fried M, Labrecque D, Bruix J, Sherman M, Omata M, Heathcote J, Piratsivuth T, Kew M, Otegbayo JA, Zheng SS, Sarin S, Hamid SS, Modawi SB, Fleig W, Fedail S, Thomson A, Khan A, Malfertheiner P, Lau G, Carillo FJ, Krabshuis J, Le Mair A. Hepatocellular carcinoma (HCC): a global perspective. J Clin Gastroenterol 2010; 44: 239-245 [PMID: 20216082 DOI: 10.1097/MCG.0b013e3181d46ef2]
2. Kouri BE, Funaki BS, Ray CE, Abou-Alfa GK, Burke CT, Darcy MD, Fidelman N, Greene FL, Harrison SA, Kinney TB, Kostelic JK, Lorenz JM, Nair AV, Nemcek AA, Owens CA, Saad WE, Vatakencherry G. ACR Appropriateness Criteria radiologic management of hepatic malignancy. J Am Coll Radiol 2012; 9: 919-925 [PMID: 23206650 DOI: 10.1016/ j.jacr.2012.09.002]
3. Mohr SE, Perrimon N. RNAi screening: new approaches, understandings, and organisms. Wiley Interdiscip Rev RNA 2012; 3: 145-158 [PMID: 21953743 DOI: 10.1002/wrna.110]
4. Lares MR, Rossi JJ, Ouellet DL. RNAi and small interfering RNAs in human disease therapeutic applications. Trends Biotechnol 2010; 28: 570-579 [PMID: 20833440 DOI: 10.1016/ j.tibtech.2010.07.009]
5. Rocheleau CE. RNA interference: Systemic RNAi SIDes with endosomes. Curr Biol 2012; 22: R873-R875 [PMID: 23098595 DOI: 10.1016/j.cub.2012.08.039]
6. Mackenzie KA, Miller AP, Hock BD, Gardner J, Simcock JW, Roake JA, Dachs GU, Robinson BA, Currie MJ. Angiogen-esis and host immune response contribute to the aggressive character of non-melanoma skin cancers in renal transplant recipients. Histopathology 2011; 58: 875-885 [PMID: 21585427 DOI: 10.1111/j.1365-2559.2011.03845.x]
7. Chen Y, Zhang L, Pan Y, Ren X, Hao Q. Over-Expression of Semaphorin4D, Hypoxia-Inducible Factor-1& amp; alpha; and Vascular Endothelial Growth Factor Is Related to Poor Prognosis in Ovarian Epithelial Cancer. Int J Mol Sci 2012; 13: 13264-13274 [PMID: 23202951 DOI: 10.3390/ijms131013264]
8. Finlay DK, Rosenzweig E, Sinclair LV, Feijoo-Carnero C, Hukelmann JL, Rolf J, Panteleyev AA, Okkenhaug K, Cantrell DA. PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells. J Exp Med 2012; 209: 2441-2453 [PMID: 23183047 DOI: 10.1084/jem.20112607]
9. Jin X, Jin HR, Lee D, Lee JH, Kim SK, Lee JJ. A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation. Eur J Pharmacol 2008; 592: 41-47 [PMID: 18639543 DOI: 10.1016/j.ejphar.2008.06.104]
10. Lee K, Kim HM. A novel approach to cancer therapy using PX-478 as a HIF-1α inhibitor. Arch Pharm Res 2011; 34: 1583-1585 [PMID: 22076756 DOI: 10.1007/s12272-011-1021-3]
11. Leontieva OV, Natarajan V, Demidenko ZN, Burdelya LG, Gudkov AV, Blagosklonny MV. Hypoxia suppresses conversion from proliferative arrest to cellular senescence. Proc Natl Acad Sci USA 2012; 109: 13314-13318 [PMID: 22847439 DOI: 10.1073/pnas.1205690109]
12. Zhou H, Fei W, Bai Y, Zhu S, Luo E, Chen K, Hu J. RNA interference-mediated downregulation of hypoxia-inducible factor-1α inhibits angiogenesis and survival of oral squamous cell carcinoma in vitro and in vivo. Eur J Cancer Prev 2012; 21: 289-299 [PMID: 22113109 DOI: 10.1097/ CEJ.0b013e32834dbbda]
13. Min L, Chen Q, He S, Liu S, Ma Y. Hypoxia-induced increases in A549/CDDP cell drug resistance are reversed by RNA interference of HIF-1α expression. Mol Med Rep 2012; 5: 228-232 [PMID: 21964646 DOI: 10.3892/mmr.2011.604]
14. Bove PF, Hristova M, Wesley UV, Olson N, Lounsbury KM, van der Vliet A. Infammatory levels of nitric oxide inhibit airway epithelial cell migration by inhibition of the kinase ERK1/ 2 and activation of hypoxia-inducible factor-1 alpha. J Biol Chem 2008; 283: 17919-17928 [PMID: 18424783 DOI: 10.1074/jbc.M709914200]
15. Keith B, Johnson RS, Simon MC. HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer 2012; 12: 9-22 [PMID: 22169972 DOI: 10.1038/nrc3183]
16. Capparelli C, Whitaker-Menezes D, Guido C, Balliet R, Pestell TG, Howell A, Sneddon S, Pestell RG, Martinez-Out-schoorn U, Lisanti MP, Sotgia F. CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth. Cell Cycle 2012; 11: 2272-2284 [PMID: 22684333 DOI: 10.4161/cc.20717]
17. Miyake K, Nishioka M, Imura S, Batmunkh E, Uto Y, Naga-sawa H, Hori H, Shimada M. The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1α targeted gene expression. Exp Cell Res 2012; 318: 1554-1563 [PMID: 22472348 DOI: 10.1016/j.yexcr.2012.03.013]
18. Shah A, Silverstein PS, Kumar S, Singh DP, Kumar A. Synergistic cooperation between methamphetamine and HIV-1 gsp120 through the P13K/Akt pathway induces IL-6 but not IL-8 expression in astrocytes. PLoS One 2012; 7: e52060 [PMID: 23251686 DOI: 10.1371/journal.pone.0052060]
19. Britschgi A, Andraos R, Brinkhaus H, Klebba I, Romanet V, Müller U, Murakami M, Radimerski T, Bentires-Alj M. JAK2/STAT5 inhibition circumvents resistance to PI3K/ mTOR blockade: a rationale for cotargeting these pathways in metastatic breast cancer. Cancer Cell 2012; 22: 796-811 [PMID: 23238015 DOI: 10.1016/j.ccr.2012.10.023]
20. Pópulo H, Lopes JM, Soares P. The mTOR Signalling Pathway in Human Cancer. Int J Mol Sci 2012; 13: 1886-1918 [PMID: 22408430 DOI: 10.3390/ijms13021886]
21. Willems L, Tamburini J, Chapuis N, Lacombe C, Mayeux P, Bouscary D. PI3K and mTOR signaling pathways in cancer: new data on targeted therapies. Curr Oncol Rep 2012; 14: 129-138 [PMID: 22350330 DOI: 10.1007/s11912-012-0227-y]
22. Bartholomeusz C, Gonzalez-Angulo AM. Targeting the PI3K signaling pathway in cancer therapy. Expert Opin Ther Targets 2012; 16: 121-130 [PMID: 22239433 DOI: 10.1517/1472 8222.2011.644788]
23. Chang LH, Chen CH, Huang DY, Pai HC, Pan SL, Teng CM. Thrombin induces expression of twist and cell motility via the hypoxia-inducible factor-1α translational pathway in colorectal cancer cells. J Cell Physiol 2011; 226: 1060-1068 [PMID: 20857420 DOI: 10.1002/jcp.22428]
24. Fu J, Chen Y, Cao J, Luo T, Qian YW, Yang W, Ren YB, Su B, Cao GW, Yang Y, Yan YQ, Shen F, Wu MC, Feng GS, Wang HY. p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinosi-tol 3-kinase/AKT/hypoxia-inducible factor-1α pathways. Hepatology 2011; 53: 181-192 [PMID: 21254169 DOI: 10.1002/ hep. 24015]
25. Polosukhin VV, Cates JM, Lawson WE, Milstone AP, Mata-fonov AG, Massion PP, Lee JW, Randell SH, Blackwell TS. Hypoxia-inducible factor-1 signalling promotes goblet cell hyperplasia in airway epithelium. J Pathol 2011; 224: 203-211 [PMID: 21557221 DOI: 10.1002/path.2863]
26. Eichmann A, Simons M. VEGF signaling inside vascular endothelial cells and beyond. Curr Opin Cell Biol 2012; 24: 188-193 [PMID: 22366328 DOI: 10.1016/j.ceb.2012.02.002]
27. Chiusa M, Hool SL, Truetsch P, Djafarzadeh S, Jakob SM, Seifriz F, Scherer SJ, Suter TM, Zuppinger C, Zbinden S. Cancer therapy modulates VEGF signaling and viability in adult rat cardiac microvascular endothelial cells and car-diomyocytes. J Mol Cell Cardiol 2012; 52: 1164-1175 [PMID: 22326847 DOI: 10.1016/j.yjmcc.2012.01.022]
28. Harashima N, Inao T, Imamura R, Okano S, Suda T, Harada M. Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells. Cancer Immunol Immunother 2012; 61: 667-676 [PMID: 22038398 DOI: 10.1007/ s00262-011-1132-1]
29. Kang S, Dong SM, Kim BR, Park MS, Trink B, Byun HJ, Rho SB. Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells. Apoptosis 2012; 17: 989-997 [PMID: 22460505 DOI: 10.1007/s10495-012-0717-2]
30. Zhou Y, Su J, Shi L, Liao Q, Su Q. DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion. Oncol Rep 2013; 29: 605-612 [PMID: 23233092 DOI: 10.3892/or.2012.2168]
31. Jung YS, Qian Y, Chen X. Examination of the expanding pathways for the regulation of p21 expression and activity. Cell Signal 2010; 22: 1003-1012 [PMID: 20100570 DOI: 10.1016/j.cellsig.2010.01.013]
32. Strzalka W, Ziemienowicz A. Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation. Ann Bot 2011; 107: 1127-1140 [PMID: 21169293 DOI: 10.1093/aob/mcq243]
33. Feng Z, Chen J, Wei H, Gao P, Shi J, Zhang J, Zhao F. The risk factor of gallbladder cancer: hyperplasia of mucous epithelium caused by gallstones associates with p16/CyclinD1/ CDK4 pathway. Exp Mol Pathol 2011; 91: 569-577 [PMID: 21777578 DOI: 10.1016/j.yexmp.2011.06.004]
34. Fu X, Tan D, Hou Z, Hu Z, Liu G. Mir-338-3p Is Down-Regulated by Hepatitis B Virus X and Inhibits Cell Proliferation by Targeting the 3'-UTR Region of CyclinD1. Int J Mol Sci 2012; 13: 8514-8539 [PMID: 22942717 DOI: 10.3390/ ijms13078514]
35. Ulici V, Hoenselaar KD, Agoston H, McErlain DD, Umoh J, Chakrabarti S, Holdsworth DW, Beier F. The role of Akt1 in terminal stages of endochondral bone formation: angio-genesis and ossification. Bone 2009; 45: 1133-1145 [PMID: 19679212 DOI: 10.1016/j.bone.2009.08.003]
36. Li GQ, Zhang Y, Liu D, Qian YY, Zhang H, Guo SY, Suna-gawa M, Hisamitsu T, Liu YQ. PI3 kinase/Akt/HIF-1α pathway is associated with hypoxia-induced epithelial-mesenchy-mal transition in fbroblast-like synoviocytes of rheumatoid arthritis. Mol Cell Biochem 2013; 372: 221-231 [PMID: 23001847 DOI: 10.1007/s11010-012-1463-z]
37. Yang XM, Wang YS, Zhang J, Li Y, Xu JF, Zhu J, Zhao W, Chu DK, Wiedemann P. Role of PI3K/Akt and MEK/ERK in mediating hypoxia-induced expression of HIF-1alpha and VEGF in laser-induced rat choroidal neovascularization. Invest Ophthalmol Vis Sci 2009; 50: 1873-1879 [PMID: 19098317 DOI: 10.1167/iovs.08-2591]
38. Hong SW, Jung KH, Lee HS, Choi MJ, Son MK, Zheng HM, Hong SS. SB365 inhibits angiogenesis and induces apoptosis of hepatocellular carcinoma through modulation of PI3K/ Akt/mTOR signaling pathway. Cancer Sci 2012; 103: 1929-1937 [PMID: 22909393 DOI: 10.1111/j.1349-7006.2012.02409.x]
39. Nakanishi C, Sato K, Ito Y, Abe T, Akada T, Muto R, Sakashi-ta K, Konno T, Kato H, Satomi S. Combined hepatocellular carcinoma and neuroendocrine carcinoma with sarcoma-tous change of the liver after transarterial chemoemboliza-tion. Hepatol Res 2012; 42: 1141-1145 [PMID: 23094854 DOI: 10.1111/j.1872-034X.2012.01017.x]
40. Shinagawa Y, Sakamoto K, Fujimitsu R, Shimakura M, Kora S, Takano K, Yoshimitsu K. Pseudolesion of the liver on ga-doxetate disodium-enhanced MR images obtained after tran-sarterial chemoembolization for hepatocellular carcinoma: clinicoradiologic correlation. AJR Am J Roentgenol 2012; 199: 1010-1017 [PMID: 23096173 DOI: 10.2214/AJR.11.8204]
41. Chan SL, Mok T, Ma BB. Management of hepatocellular carcinoma: beyond sorafenib. Curr Oncol Rep 2012; 14: 257-266 [PMID: 22434314 DOI: 10.1007/s11912-012-0233-0]